Oric Pharmaceuticals ORIC
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$45.30M-16.0% YoY
Net profit-$41.49M-14.1% YoY
Diluted EPS-$0.38+19.1% YoY
Free cash flow-$31.96M-3.4% YoY
Operating cash flow-$31.61M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-39.8%
Return on assets-37.4%
Return on invested capital-39.4%
Current ratio13.19
Liabilities / assets5.8%
Cash & investments$264.76M
Net cash (debt)$264.76M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $45.30M | $39.62M | $143.00M | $34.55M | $36.67M |
| Selling and Admin Expenses | $9.00M | $8.18M | $33.19M | $8.70M | $7.90M |
| -General & Admin Expense | $9.00M | $8.18M | $33.19M | $8.70M | $7.90M |
| Research & Development | $36.30M | $31.44M | $109.82M | $25.86M | $28.77M |
| Operating Profit | -$45.30M | -$39.62M | -$143.00M | -$34.55M | -$36.67M |
| Other Income (Expense) | $3.80M | $3.85M | $13.54M | $4.05M | $4.08M |
| Other Non-Operating Income (Expenses) | $3.80M | $3.85M | $13.54M | $4.05M | $4.08M |
| Pretax Profit | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Net Profit | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Profit from Continuing Operations | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Net Income to Parent Company | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Net Income to Common Stockholders | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Basic EPS | -$0.38 | -$0.34 | -$1.47 | -$0.30 | -$0.33 |
| Diluted EPS | -$0.38 | -$0.34 | -$1.47 | -$0.30 | -$0.33 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $404.69M | $436.76M | $408.89M | $408.89M | $431.19M |
| Total Current Assets | $273.70M | $290.23M | $288.47M | $288.47M | $295.59M |
| Cash and Cash Equivalents & Short-Term Investments | $264.76M | $281.93M | $281.49M | $281.49M | $287.14M |
| -Cash and Cash Equivalents | $37.48M | $56.40M | $45.67M | $45.67M | $49.67M |
| -Short Term Investments | $227.28M | $225.54M | $235.82M | $235.82M | $237.47M |
| Other Current Assets | $8.93M | $8.30M | $6.98M | $6.98M | $8.45M |
| Total Non-Current Assets | $130.99M | $146.53M | $120.42M | $120.42M | $135.60M |
| Net PPE | $2.24M | $2.15M | $2.42M | $2.42M | $2.56M |
| -Gross PPE | $10.43M | $10.07M | $10.07M | $10.07M | $10.72M |
| -Accumulated Depreciation | -$8.19M | -$7.92M | -$7.65M | -$7.65M | -$8.16M |
| Investments and Advances | $122.80M | $137.78M | $110.76M | $110.76M | $125.91M |
| -Available for Sale Securities | $122.80M | $137.78M | $110.76M | $110.76M | $125.91M |
| Other Non-Current Assets | $5.95M | $6.60M | $7.25M | $7.25M | $7.13M |
| Total Liabilities | $23.43M | $21.21M | $24.53M | $24.53M | $24.27M |
| Total Current Liabilities | $20.76M | $17.77M | $20.42M | $20.42M | $20.18M |
| Payables | $3.87M | $2.90M | $3.82M | $3.82M | $2.90M |
| -Accounts Payable | $3.87M | $2.90M | $3.82M | $3.82M | $2.90M |
| Current Accrued Expenses | $8.44M | $7.78M | $5.17M | $5.17M | $7.11M |
| Short-Term Debt and Capital Lease Obligation | $3.33M | $3.30M | $3.33M | $3.33M | $3.30M |
| -Current Capital Lease Obligation | $3.33M | $3.30M | $3.33M | $3.33M | $3.30M |
| Total Non-Current Liabilities | $2.67M | $3.43M | $4.11M | $4.11M | $4.09M |
| Other Non-Current Liabilities | $2.67M | $3.43M | $4.11M | $4.11M | $4.09M |
| Total Equity | $381.26M | $415.56M | $384.36M | $384.36M | $406.92M |
| Stockholders' Equity | $381.26M | $415.56M | $384.36M | $384.36M | $406.92M |
| Capital Stock | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -Common Stock | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.15B | $1.14B | $1.08B | $1.08B | $1.07B |
| Retained Earnings | -$769.50M | -$728.01M | -$692.24M | -$692.24M | -$661.74M |
| Gains/Losses Not Affecting Retained Earnings | -$1.02M | -$290,000.00 | $786,000.00 | $786,000.00 | $615,000.00 |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$31.61M | -$32.44M | -$110.97M | -$22.48M | -$25.11M |
| Net cash flow from continuing operations | -$31.61M | -$32.44M | -$110.97M | -$22.48M | -$25.11M |
| Net Income from Continuing Operations | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| Depreciation & Depletion & Amortization | $264,000.00 | $270,000.00 | $1.22M | $320,000.00 | $288,000.00 |
| Change in Working Capital | $2.24M | -$4.00M | -$5.46M | $1.66M | $2.14M |
| -Change in Prepaid Assets | $21,000.00 | -$679,000.00 | $1.79M | $2.11M | $782,000.00 |
| -Change in Payables and Accrued Expense | $2.22M | -$3.32M | -$7.25M | -$448,000.00 | $1.36M |
| Net cash flow from investing | $11.86M | -$17.98M | -$148.03M | $16.98M | -$110.54M |
| Net Cash Flow from Continuing Investing Activities | $11.86M | -$17.98M | -$148.03M | $16.98M | -$110.54M |
| Net PPE Purchase and Sale | -$356,000.00 | -$2,000.00 | -$712,000.00 | -$227,000.00 | -$35,000.00 |
| Net Investment Purchase and Sale | $12.22M | -$17.97M | -$147.32M | $17.21M | -$110.50M |
| Financing Cash Flow | $828,000.00 | $61.14M | $245.26M | $1.50M | $109.45M |
| Net Cash Flow from Continuing Financing Activities | $828,000.00 | $61.14M | $245.26M | $1.50M | $109.45M |
| Net Common Stock Issuance | $0.00 | $60.88M | $244.37M | $0.00 | $110.44M |
| Proceeds from Stock Option Exercised | $828,000.00 | $1.25M | $3.29M | $1.50M | $748,000.00 |
| Net Other Financing Charges | $0.00 | -$993,000.00 | -$2.40M | $0.00 | -$1.74M |
| Ending Cash Balance | $37.97M | $56.89M | $46.16M | $46.16M | $50.16M |
| Net Change in Cash | -$18.91M | $10.73M | -$13.74M | -$4.00M | -$26.20M |
| Beginning Cash Balance | $56.89M | $46.16M | $59.90M | $50.16M | $76.36M |
| Free Cash Flow | -$31.96M | -$32.44M | -$111.68M | -$22.71M | -$25.15M |
No comments yet — be the first to weigh in on ORIC.
Sign in to join the discussion.